C12N 2501/37
Parathyroid hormone [pth]
Official title: Parathyroid hormone [PTH]
C12N2501/37 (Parathyroid hormone [pth]) appears on 19 US grants and 33 published applications in this corpus.
Search patents in C12N- Granted patents
- 19
- Published applications
- 33
- Assignees
- 15
- Inventors
- 55
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 3 |
| 2005 | 0 | 0 |
| 2006 | 0 | 3 |
| 2007 | 0 | 2 |
| 2008 | 1 | 1 |
| 2009 | 1 | 3 |
| 2010 | 1 | 1 |
| 2011 | 2 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 2 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 1 | 2 |
| 2023 | 0 | 1 |
| 2024 | 2 | 1 |
| 2025 | 1 | 4 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- In-vitro culture, induction, activation and cryopreservation method and cell bank establishment for immune cells5 Aug 2025US 12,376,584 B2
- Serum-free complete medium for inducing differentiation of a mesenchymal stem cell to a corneal epithelial cell18 Jun 2024US 12,012,611 B2Qingdao Restore Biotechnology Co., Ltd.
- Inducer for inducing a mesenchymal stem cell to differentiate into an islet cell18 Jun 2024US 12,012,614 B2Qingdao Restore Biotechnology Co., Ltd.
- Compositions for treatment of osteochondral disorders18 Oct 2022US 11,471,492 B2Katholieke Universiteit Leuven
- Cells expressing parathyroid hormone 1 receptor and uses thereof31 Aug 2021US 11,103,537 B2Tithon Biotech Inc.
- Cells expressing parathyroid hormone 1 receptor and uses thereof24 Sep 2026US 2026/0286293 A1Tithon Biotech Inc.
- Cells expressing parathyroid hormone 1 receptor and uses thereof17 Sep 2026US 2026/0275277 A1Tithon Biotech Inc.
- Method for producing milk like products25 Sep 2025US 2025/0297216 A1Societe des Produits Nestle S. A.
- Method for producing milk like products10 Jul 2025US 2025/0223550 A1Societe des Produits Nestle S. A.
- Medium composition for culturing urine-derived stem cell, method for isolating and culturing urine-derived stem cell using same, urine-derived stem cell with improved therapeutic function for renal disease, and cell therapy product composition containing same19 Jun 2025US 2025/0195578 A1
Most cited
By later US patents
- Serum-free cell growth medium27US 6,617,161 B2The United States of America as represented by the Department of Health and Human Services · 2003
- Regulation of cell proliferation and differentiation using peptides18US 5,527,772 A1996
- Regulation of cell proliferation and differentation using peptides18US 5,840,690 A1998
- Regulation of cell proliferation and differentiation using peptides18US 6,066,618 A2000
- Tissue engineering methods and compositions17US 8,691,542 B2Cytex Therapeutics, Inc. · 2014